Yukio Hosomi

15PUBLICATIONS
87CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPredictive and prognostic markersMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Dec 22, 2025
Diagnostically Challenging Disseminated Bacillus Calmette-Guerin Infection With Lung and Liver Involvement: A Case Report.

Shinichi Chang, Makiko Yomota, Ayumi Takizawa

|Mar 31, 2025
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation.

Shintaro Kanda, Seiji Niho, Takayasu Kurata

|Aug 09, 2024
Durvalumab plus platinum-etoposide chemotherapy for extensive-stage small cell lung cancer: a retrospective real-world study.

Kazuhito Misawa, Kageaki Watanabe, Masahiro Seike

|Jun 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.

Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata

|Nov 30, 2023
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.

Yuto Terashima, Taiki Hakozaki, Yuji Uehara

Pageof 3

Frequent Collaborators

4 joint publications

Taiki Hakozaki

2 joint publications

Yuji Uehara

2 joint publications

Eisaku Miyauchi

2 joint publications

Katsuhiko Naoki